Introduction
Both exogenous and endogenous DNA damage cause mutations. Mutagenic lesions are those that inhibit DNA replication or those that allow replication to proceed with diminished fidelity. As a consequence of their 'bypass' different types of mutations may be introduced: deletions, insertions and point mutations either transitions or transversions. Since the pioneering work of Benzer (1) and Miller [for a review see (2) ] it is known that these permanent changes of the genome are the result of the direct interaction of the carcinogen with DNA. Carcinogens induce specific modifications of DNA, DNA-adducts, and their processing into mutations leads to what is known as a mutational spectrum, i.e. to a pattern of mutations that is often unique (in terms of type and sequence) of that specific carcinogen. This knowledge has suggested that the analysis of the site and nature of DNA changes in certain tumours might be useful in identifying the 'cause' of the tumour. However, mutational spectra are 'a many protein affair' (3) and therefore their interpretation is influenced and complicated by a series of factors. First, the analysis of mutations is always biased in some way since it is based on the window of observation of the selective mutation system used. If the detection system monitors the function of a protein mutation analysis will be confined to those genetic alterations that produce a functionally altered gene product. A mutagen will generally introduce a variety of lesions with different mutagenic potential. The primary sequence of the target gene will be one of the factors affecting the site-specificity of the lesion. The cell metabolism reflects another layer of complexity. Mutations will be affected by the efficiency of repair as well as by the replicative bypass efficiency and insertion preference. All these variables should be taken into account when we attempt to go 'from a gene to a carcinogen' (4).
The cell metabolism
The carcinogen-induced mutational spectra obtained in bacterial and mammalian cells in culture are used as a reference in the interpretation of the mutation profiles of cancer-related genes. However, the extrapolation of in vitro data to human carcinogenesis can be misleading if the metabolism of the in vitro cell system is not carefully evaluated. I have selected two studies (5, 6 ) from the literature whose results are particularly relevant to this issue. The mutational spectra of the Nnitroso ethylating carcinogens have been widely explored in mammalian cells in culture (7, 8) . The predominant base pair © Oxford University Press alterations detected were GC-»AT transitions (almost 50% of all mutations), in agreement with the miscoding properties of C^-ethylguanine adducts (9) . However, when mutational spectra induced by /V-ethyl-ZV-nitrosourea were analysed in the hprt gene of skin fibroblasts of rats exposed in vivo to this carcinogen, a different mutation profile was observed. GC-»AT transitions were only present at low frequency (12% of all mutations) and the predominant mutations were transversions targeted at AT base pairs (5) . The majority of mammalian cell lines used for mutagenicity studies are deprived of O 6 -methylguanine-DNA-methyltransferase (MGMT*). The lack of (Aalkylguanine repair gives rise to very high mutation frequencies and the persistence of these adducts leads, as expected, to high yields of GC->AT transitions. Moreover, the doses of the carcinogen used in in vitro experiments are usually high and therefore MGMT, if present, can be easily saturated. Ethylating carcinogens induce, besides C^-ethylguanine, less frequent lesions, like C^-ethylthymine and 0 4 -ethylthymine, that are important mutagenic lesions (10, 11) . It is likely that in vivo the cellular MGMT activity is sufficient to repair the majority of C^-ethylguanine adducts, thus leaving as main contributors to mutagenesis the O-ethylpyrimidines that lead to an excess of mutations at AT base pairs.
The second study (6) explored the dose-dependent mutagenesis of N-methyl-Af'-nitro-N-nitrosoguanidine in the hprt gene of human fibroblasts in culture after exposure to low and high doses of this carcinogen. Two different mutation patterns were obtained: at low doses both transitions and transversions were observed predominantly targeted at AT base pairs whilst at high doses the GC->AT transitions were the major mutagenic event. This phenomenon can also be explained by the emergence in the mutation profile of the 'signature' of minor lesions when the repair pathway for the main premutagenic lesion, C^-methylguanine, is fully efficient (at low doses). Therefore, care must be taken in extrapolating in vitro mutagenesis data to mutations detected in vivo in different tumour target tissues and presumably due to exposure to very low doses of environmental carcinogens.
The 'protein filter'
The mutational spectrum detected in a gene is strongly affected by the primary sequence of the gene and by the structure of the target protein that will determine the mutable sites. The distribution of mutations along any gene is not uniform. The number of mutations at a given base pair reflects the mutability of a particular site by a given agent (initial adduct formation, adduct removal, efficiency of misinsertion, etc.) while the mutable sites reflect the functional domains of the protein. A good example of the screen due to the structure of the target protein is given by the analysis of N-methyl-./V-nitrosourea (MNTJ)-induced mutations in the gpt gene carried by a shuttle vector episomically mantained in human cells (12) . Mutations were predominantly GC->AT transitions preferentially targeted at G residues preceeded in 5' by a purine (mainly a G) and located on the non-transcribed DNA strand. The distribution of mutable sites (5'GG3' sequences mutable via a G-»A transition at the 3' G) is biased towards the nontranscribed gpt strand (2:1 in favour of the non-transcribed strand) partially accounting for this asymmetry. Moreover, the profile of the expected mutable sites can differ significantly from the real map of the mutable sites of a given target protein since proteins are highly tolerant of amino acid substitutions (13) . In fact, when MNU-induced mutations were identified by using a non-selective method, the RFLP/PCR assay, to discriminate mutated sequences from wild-type DNA, we observed that gpt genes containing a G-»A mutation targeted at 4/5 G residues of the /Veil recognition sequence (5'CCGGG3') were still coding for a fully functional GPT protein (14) ( Figure 1A ). Only one of the /Veil mutations, which is located at a G residue on the non-transcribed strand (Gi 28 ), drastically affected the structure of the target protein and in fact it was identified as a hot-spot mutation by phenotypic analysis. The Neil mutations were randomly distributed in both strands of the gpt gene, indicating that the main contributor to strand specificity in this sequence, and likely in all the gpt gene, is the structure of the GPT protein.
Mutant p53 genes have been sequenced from more than 2000 clinical cancers and the new structural information on p53 (15) had clearly shown that the hot-spot mutations sites detected in several tumours are well explained by the structure of the p53 protein itself. In fact, each of the hot-spot mutation alters or destabilizes the central domain of the protein such that it is no longer able to interact properly with cognate DNA sites (16) . Analysis of mutational spectra of the p53 gene in a variety of tumours has revealed strand bias for mutation in the non-transcribed DNA strand, leading to the proposal of using mutation strand bias as an indicator of environmental tumour aetiology (17) . However, also in this case, the changes in protein structure and activity might account for the unequal frequency of a p53 mutational event at a given codon. A good example is given by the p53 hot-spot mutation at codon 175 ( Figure IB ). Soussi and coworkers (18) have shown that the striking unbalance for mutations at the CpG site between the two strands is fully explained by the conformation and biological activity of the p53 mutation. In fact the His n5 mutant (due to a G-»A transition at the G on the non-transcribed strand) is clearly mutant both on the basis of its conformation as well as of its biological activity, while the mutant Cys l75 (due to a G-»A transition at the G on the transcribed strand) exhibits wild-type properties. Therefore, also in the case of the p53 gene, the occurrence of a mutation is affected by the resulting amino acid change, eventually leading to synthesis of a p53 conferring a growth advantage on the cell.
Transcription-associated repair
Since the transcribed strand of active genes is preferentially repaired, the potential of a lesion to cause mutation should depend on whether it is located on the transcribed or nontranscribed DNA strand of active genes. Preferential targeting of mutations on the non-transcribed DNA strand of different target genes has been described by several authors after' treatment with SN r type methylating agents. It is well established that /V-methylpurines are not preferentially removed •from human active genes (19) , but whether the main premutagenic alkyl-lesions like C^-methylguanine and C^-methylthymine are strand-specifically repaired is still a matter of investigation. Recently, it has been shown that C^-ethylguanine adducts are preferentially repaired from the transcribed genes of rat hepatoma cells (20) , but also in this case it is not known whether this repair is strand-specific. By using different approaches, two studies (12, 21) have investigated whether mutation distribution induced by methylating carcinogens is affected by strand-specific repair. In our laboratory a shuttle vector system has been used that carries as target gene for mutation analysis, the gpt gene under the control of the metallothionein-I (MT-I) promoter, which confers metal responsivity to the gpt gene. This EBV-derived shuttle vector is episomically mantained in human cells and by adding zinc ions to the cell growth medium the level of gpt transcription can be increased up to 50-fold (22) . MNU-induced mutations were analysed as a function of the transcriptional activity of the gpt gene (from highly expressed to silent) (12) . In the study by McGregor et al. (23) MNNG-mutation type and strand distribution were investigated in the hprt gene of human fibroblasts with high levels of MGMT and after depletion of the enzyme by C^-benzylguanine (23) . In both types of experiments the majority of mutations observed were GC->AT transitions preferentially located on the non-transcribed strand independently of the transcriptional activity of the gene ( Figure  2 , left) and/or of the repair efficiency of the mutagenic lesions (Figure 2, right) . These findings rule out the hypothesis that, in the case of methylating carcinogens, mutation strand bias is due to strand-specific excision repair. The distribution of mutable sites over the two strands remains the most likely explanation for this phenomenon.
What happens when lesions that are a substrate for the transcription-coupled repair are processed into a mutation? When mutation distribution is analysed in the case for UV damage, the 'fingerprint' of this asymmetric repair is sometimes clearly visible in mutational spectra. This is the case of UVinduced mutational spectra in hamster cells. In repair-proficient rodent cells, almost all cyclobutane dimers are lost from the transcribed strand of active genes within 8 h, whereas essentially no dimer loss is detected from the non-transcribed DNA strand even 24 h post-irradiation (24, 25) . Accordingly, >85% of UV-induced mutations can be attributed to dipyrimidine lesions in the non-transcribed strand of the hprt gene (24, 27) . Human cells also efficiently repair the transcribed strand of active genes, but the difference in the rate of dimer removal from the two strands is not as striking as in the case of rodent cells. In fact, no difference between the two strands is detected at 24 h post-irradiation (24, 27) .The strand distribution of UVinduced mutations at the gpt gene in our shuttle vector system was preferentially on the transcribed strand and was not affected by the transcriptional level of the gpt gene (from basal to induced) (28) (Figure 3, left) . Although 70% of the dimers were removed from the shuttle vector genome within 8 h after irradiation, mutation distribution was that expected on the basis of the 'protein filter'. The preferential targets for UV mutagenesis, CC and CT sites, are also a target for MNU mutagenesis as GG and AG dinucleotides on the opposite strand (see above). Therefore, the inversion of strand bias between MNU-and UV-induced mutations is a strong argument in favour of a key role played by the structure of the target protein in determining mutation strand distribution.
In human fibroblasts a similar strand bias in favour of the transcribed DNA strand was reported for UV-induced hprt mutations in cells irradiated in the S-phase, while an inversion of the strand bias was reported in G,-synchronized fibroblasts (23) (Figure 3, right) . In this last case the majority of mutations were located on the non-transcribed strand as expected from preferential repair of the transcribed DNA strand. In human cells the use of synchronized cell populations irradiated in Gj seems to be necessary in order to see the effect of strandspecific repair on mutation distribution.
When UV-induced mutational spectra were analysed in XP-A human fibroblasts, which are unable to excise UV-induced DNA damage, both S and Gj cells showed a bias for mutations localized on the transcribed strand (23, 29) . The same strand bias was also reported in nucleotide excision repair deficient hamster cell lines (26, 30) . This phenomenon has been ascribed to large differences in replication fidelity of the leading and lagging strands. In this model the transcribed strand of the hprt gene would be synthesized by a more error-prone DNA polymerase than the complementary strand. Although the anatomy of the replication machinery in. eukaryotic cells has not been clarified yet, data from replication fidelity studies in mammalian cells would indicate that both strands are synthesized with high fidelity (see below). Moreover, since the bias in favour of the transcribed strand of the hprt gene has also been observed in S-synchronized repair proficient cells (28) (where in the absence of repair the distribution of UV-induced mutations should merely reflect the distribution of mutable sites on the target gene), the bias in repair-deficient cells is more likely to reflect selection for non-functional HPRT protein.
On the basis of these findings, the lack of strand bias of p53 mutations in skin cancers associated with UV exposure is not surprising. If all p53 mutations currently identified in association with skin cancer (31-37, D'Errico etal, submitted) are considered, they are all targeted at dipyrimidine sites (as expected from UV-induced mutations) and they are almost evenly distributed between the two strands (Figure 4) . The removal of cyclobutane pyrimidine dimers occurs efficiently from both p53 strands, although the transcribed strand is repaired more rapidly than the non-transcribed strand (38, 39) . As in the case of the gpt and hprt genes, the rate of strand-specific repair might be insufficient to affect mutation distribution. In fact, in murine systems that repair, very inefficiently, the non-transcribed DNA strand, a significant strand bias of UV-induced p53 mutations towards the nontranscribed DNA strand was reported (40, 41) . Therefore the rate of strand-specific repair of the target cells should be taken into consideration when mutation strand bias is analysed.
A strand bias for p53 mutation distribution was reported in XP skin tumours (42) . p53 Mutations were preferentially located at CC sequences on the non-transcribed DNA strand . The authors suggested that the residual repair capacity of these cells is selectively active on the lesions located on the 2116 transcribed strand thus leaving premutagenic UV lesions on the non-transcribed DNA strand. These data are in contrast with mutation strand distribution in UV-irradiated cultured XP cells (28, 29) . Plausible explanations for these differences are: (i) the functional constraints of the target proteins (p53 and HPRT respectively); (ii) the clonal expansion of cells containing specific p53 mutations in skin tumour progression; and/or (iii) the direction of replication within the target genes.
Leading and lagging strand synthesis
DNA replication is an asymmetric process and several laboratories have been interested in whether such asymmetry might lead to differences in error rates for leading and lagging strand replication. The effect of this asymmetry on mutagenesis in bacterial cells has been clearly shown by using plasmids containing the ColEl origin of replication and a single N-2-acetylaminofluorene (AAF) C-8 guanine adduct in the leading or lagging strand (43) . Mutations arose at ~20-fold higher frequency when the AAF adduct was located in the lagging strand than when in the leading strand. In contrast, in eukaryotic cells several lines of evidence would indicate that the exonucleolitic proof-reading occurs with the same efficiency in both strands when the template is either undamaged or damaged DNA. By using an SV40 origin-dependent replication of plasmid DNA in human cell extracts, Kunkel and coworkers (44) have shown that there is no difference in fidelity between leading and lagging strand synthesis for both spontaneous base substitution errors and deletions. Also in the case of translesion synthesis of UV-irradiated DNA the error probability was the same during leading and lagging strand replication (45) . An effect was only observed in the rate of substitution probability at the same sequence when replicated as the leading or lagging strand. Similarly, by using an EBV-derived shuttle vector containing the gpt gene in both orientations relative to the EBV origin, no difference neither in mutation frequency nor in mutation type was observed when cells harbouring the vector were UV-irradiated (46) . The distribution of errors showed that some sites were mutagenically independent of the replication mode, while the overall site and sequence specificity of mutations seemed to vary between the two strands. The same approach was used to investigate the bypass of alkylated lesions during leading and lagging strand synthesis (47) . Also in this case the mutation frequency was not affected by the directionality of the replication complex indicating that the overall average mutation probability on an alkylated substrate is the same during leading and lagging strand replication. Moreover, the striking similarity between mutation distribution and sequence specificity in the leading versus the lagging strand, with 75% of the target sites in common, indicates that mutagenic translesion replication does not change when the same sequence is replicated as the leading or the lagging strand. The availability of specific sites for alkylation and/or repair of alkylated bases seems to dictate the rules for alkylation mutation pattern.
Therefore the human leading and lagging DNA strand replication apparatus edits spontaneous or induced mispairs efficiently on both strands eventually affecting mutation probability at certain sequences more than the overall error rate.
However, it is important to recall that the systems used to investigate DNA replication in eukaryotes (i.e. the in vitro SV40 replication assay and the EBV-derived shuttle vectors) do not reproduce completely the replication of relatively long replicons such as those present in eukaryotic cells. Moreover, differential replication of a single UV lesion contained in the leading and lagging strand has been reported by human cell extracts in the SV40 minireplicon (48) raising the possibility that in the in vitro replication-mutagenesis assay the recovery of mutations is biased towards one strand. The progress in the knowledge of the fine anatomy and function of the eukaryotic replication fork might reserve some surprise.
In conclusion, the analysis'of mutational spectra in cancerrelated genes should be considered as a valuable tool that allows for predictions to be made on the carcinogen responsible for a certain type of tumour. A clear example is given by the analysis of p53 mutations in skin carcinomas. However, the interpretation of tumour gene mutations should adhere to a careful evaluation of all the factors that, besides the direct interaction of the carcinogen with DNA, are known to be potential modifiers of both mutation type and distribution.
